Business Parks & Science Centres



Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 55 56 57 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Ganymed Pharmaceuticals AG. (9/11/13). "Press Release: Ganymed Pharmaceuticals Announces CE Marking for Test to Assess Claudin-18.2 Expression in Solid Tumors". Mechelen. 2013-09-11
Markes International Ltd.. (9/11/13). "Press Release: Markes International GmbH Opens in Frankfurt, Germany". 2013-09-11
Anagnostics Bioanalysis GmbH. (9/10/13). "Press Release: Anagnostics’ Inflammation Monitoring Applied by Vienna’s Wilhelmine Hospital". 2013-09-10
Bayer AG. (9/10/13). "Press Release: Personalized Oncology. Bayer and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy [Not intended for U.S. Media]". Leverkusen & Berlin. 2013-09-10
Inovio Pharmaceuticals, Inc.. (9/10/13). "Press Release: Roche and Inovio Pharmaceuticals Partner On Inovio’s Prostate and Hepatitis B Immunotherapy Products". Basel & Blue Bell, PA. 2013-09-10
Sernova Corporation. (9/10/13). "Press Release: Sernova and Medicyte to Collaborate on Cell-based Therapy to Treat Haemophilia. Novel Approach to Address Unmet Need for an Effective Therapy". London, ON & Heidelberg. 2013-09-10
Activaero GmbH. (9/9/13). "Press Release: Activaero and Chiesi Enter into Research Collaboration for Novel Drug Device Combination in Cystic Fibrosis". Gemünden/Wohra. 2013-09-09
Debiopharm S.A.. (9/9/13). "Press Release: Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm". Lausanne & Kolkata. 2013-09-09
Evolva Holding S.A.. (9/9/13). "Press Release: Cargill and Evolva Move into Pilot Scale ahead of Schedule for Fermentation-based Steviol Glycosides". Minneapolis, MN & Reinach. 2013-09-09
Genkyotex S.A.. (9/9/13). "Press Release: Genkyotex Receives FDA IND Approval for Phase II Clinical Study with First in Class NOX Inhibitor GTK137831". Geneva & Archamps. 2013-09-09
High-Tech Gründerfonds Management GmbH. (9/9/13). "Press Release: Neurodyn Inc. Acquires Memogain for Dementia in Alzheimer’s Disease". Bonn & Mainz & Charlottetown. 2013-09-09
Paion AG. (9/9/13). "Press Release: Paion Starts Phase II Study with Remimazolam in the Indication Anaesthesia". Aachen. 2013-09-09
Bruker Corporation. (9/9/13). "Press Release: Bruker Introduces New Benchtop FT-NMR System Fourier 60". Indianapolis, IN. 2013-09-09
Novartis AG. (9/6/13). "Press Release: Novartis Announces an Exclusive Global Licensing and Research Collaboration with Regenerex, Leveraging a Novel Cell Platform to Broaden Presence in the Cell Therapy Space". Basel. 2013-09-06
Scienion AG. (9/6/13). "Press Release: MicroAcqua – a 12 Party Consortium Drives the Development of a Microarray for a Rapid, Inexpensive and Effienct Testing for Waterborne Pathogens". Dortmund & Berlin. 2013-09-06
Taros Chemicals GmbH & Co. KG. (9/6/13). "Press Release: Taros Announces Appointment of New Director of Medicinal Chemistry". Dortmund. 2013-09-06
Wilex AG. (9/6/13). "Press Release: Nuclea Biotechnologies Inc. Acquires Wilex Inc. and Extends Their Cooperation with Wilex AG. Nuclea Purchased All Shares of Wilex Inc. (Oncogene Science)". Munich & Pittsfield, MA & Cambridge, MA. 2013-09-06
Enzymatics, Inc.. (9/6/13). "Press Release: Enzymatics Acquires ArcherDx and Next-Generation Diagnostic Technology. Jason Myers, Ph.D., Co-founder and Chief Executive Officer of ArcherDx, Joins Enzymatics as Chief Scientific Officer". Beverly, MA & Bould 2013-09-06
Apceth GmbH & Co. KG. (9/5/13). "Press Release: Apceth Names Dr Stefanos Theoharis Chief Business Officer". Munich. 2013-09-05
Debiopharm S.A.. (9/5/13). "Press Release: Go To Market Consulting Inc. and Debiopharm Group Collaborate to Identify Early Stage In-licensing Opportunities on the US West Coast". Lausanne & San Francisco, CA. 2013-09-05
Piqur Therapeutics AG. (9/5/13). "Press Release: Piqur Successfully Closed a Third Seed Financing Round and Received Eurostars Grant". Basel. 2013-09-05
Analytik Jena AG. (9/4/13). "Press Release: Analytik Jena AG Approves a Subscription Rights Capital Increase of up to 1.95 Million New Shares (Ad-hoc notification in accordance with Section 15 WpHG [Securities Trading Act])". Jena. 2013-09-04
Genedata AG. (9/4/13). "Press Release: Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening". Basel. 2013-09-04
High-Tech Gründerfonds Management GmbH. (9/4/13). "Press Release: HTGF Invests in Novel Approach for the Treatment of Obesity and Diabetes Type II – Perora". Bonn. 2013-09-04
Roche. (9/4/13). "Press Release: Start of the TROPICAL-ACS Large Intervention Study on Multiplate-guided Anti-platelet Therapy in ACS Patients". Rotkreuz. 2013-09-04
Ventana Medical Systems, Inc.. (9/4/13). "Press Release: Ventana and EMC Join Forces to Take Digital Pathology into the World of Big Data". Tuscon, AZ. 2013-09-04
Medicyte GmbH. (9/4/13). "Press Release: Taconic and Medicyte Announce Strategic Marketing Alliance. Taconic to Distribute Medicy Human upcyte Hepatocyte Products". New York & Heidelberg. 2013-09-04
Thermo Fisher Scientific Inc.. (9/4/13). "Press Release: Thermo Fisher Scientific and Siemens Renew Partnership for Improved Detection of Sepsis Using B.R.A.H.M.S PCT Biomarker. Procalcitonin (PCT) Immunoassay Availabiltiy Is Continued on ADVIA Centaur S 2013-09-04
Apitope International N.V.. (9/3/13). "Press Release: Apitope Announces Positive Results from Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis". Bristol & Hasselt. 2013-09-03
Leukocare AG. (9/3/13). "Press Release: Leukocare Announces EUR 3.4 M Capital Increase". Munich. 2013-09-03
Santhera Pharmaceuticals. (9/3/13). "Press Release: Santhera Closes License-back Deal with Takeda for European Rights to Catena in Duchenne Muscular Dystrophy". Liestal. 2013-09-03
Zealand Pharma A/S. (9/3/13). "Press Release: Zealand Appoints New Chief Scientific Officer. Dr Torsten Hoffmann Joins from Roche". Copenhagen. 2013-09-03
Diaxonhit S.A.. (9/3/13). "Press Release: Diaxonhit Signs a Research Service Agreement with Boehringer Ingelheim for the Discovery of Novel Epitope Targets". Paris. 2013-09-03
Genedata AG. (9/3/13). "Press Release: Genedata Screener Extends Support for High-throughput Thermofluor Assays". Basel. 2013-09-03
Novartis AG. (9/3/13). "Press Release: Novartis Receives EU Approval for Ilaris in Active Systemic Juvenile Idiopathic Arthritis, a Serious Form of Childhood Arthritis". Basel. 2013-09-03
Vela pharmazeutische Entwicklung und Laboranalytik GmbH (Vela Laboratories). (9/3/13). "Press Release: Vela Laboratories and Evercyte Announce Cooperation to Provide Immortalized Cell Lines for Biosimilar Characterization". Vienna. 2013-09-03
Therametrics Holding AG. (9/3/13). "Press Release: Therametrics Holding AG (SIX: TMX) Today Announces the Resignation of Mr. Ruggero Gramatica as CEO and Director as of the End of September 2013 and the Appointment of Mr. Raffaele Petrone as New CEO with 2013-09-03
Arsanis, Inc.. (9/3/13). "Press Release: Arsanis Inc Closes $20 Million Series B Financing". Vienna. 2013-09-03
Sartorius AG. (9/3/13). "Press Release: Sartorius Stedim Biotech Signs Long-term Syndicated Loan. Credit Volume at 250 Million Euros – International Bank Syndicate Led by Commerzbank and Nord/LB". Aubagne & Goettingen. 2013-09-03
Advent International. (9/2/13). "Press Release: Former Sanofi President Hanspeter Spek Joins Advent International’s Operating Programme". London. 2013-09-02
High-Tech Gründerfonds Management GmbH. (9/2/13). "Press Release: High-Tech Gründerfonds Invests in Young Bioprocess Technology Company – PS Biotech". London. 2013-09-02
Metrohm. (9/2/13). "Press Release: New »Work Horse« for Routine Analysis – Metrohm Introduces 930 Compact IC Flex Ion Chromatograph". 2013-09-02
Metrohm. (9/2/13). "Press Release: 940 Professional IC Vario – Metrohm Launches New High-performance Ion Chromatography System". 2013-09-02
Wilex AG. (9/2/13). "Press Release: Wilex Subsidiary Heidelberg Pharma Signs License Agreement for the Development of Antibody Targeted Amanitin Conjugates (ATACs) with Roche". Munich. 2013-09-02
Novartis AG. (9/2/13). "Press Release: Novartis’ Serelaxin (RLX030) Improved Symptoms and Mortality across Multiple Subgroups of Patients with Acute Heart Failure". Basel. 2013-09-02
Roche. (9/2/13). "Press Release: Roche’s New Timesaving Formulation of Herceptin Approved in Europe for the Treatment of HER2-positive Breast Cancer". Basel. 2013-09-02
Amgen GmbH. (9/2/13). "Pressemitteilung: Cristophe Bourdon ist neuer Deutschlandchef der Amgen GmbH". München. 2013-09-02
Evotec AG. (8/31/13). "Press Release: Evotec Raises € 30 m from Biotechnology Value Fund". Hamburg. 2013-08-31
Thermo Fisher Scientific Inc.. (8/30/13). "Press Release: Thermo Fisher Scientific and the Technical University of Denmark for Systems Biology Form Collaboration". San José, CA & Copenhagen. 2013-08-30
Sartorius AG. (8/30/13). "Press Release: The Supervisory Board of Sartorius AG Extends Reinhard Vogt’s Appointment to the Executive Board". Göttingen. 2013-08-30
Santhera Pharmaceuticals Holding AG. (8/30/13). "Press Release: Santhera Successfully Concludes Restructuring in First Half Year of 2013". Liestal. 2013-08-30
Universität Graz. (8/29/13). "Pressemitteilung: Hochdotierte EU-Förderung. Rudolf Zechner, Biochemiker der Uni Graz, erhält 2,5 Millionen Euro ERC Advanced Grant für Stoffwechselforschung". 2013-08-29
ObsEva S.A.. (8/29/13). "Press Release: ObsEva SA Announces CHF 32 Million Series A Funding from Leading Venture Capital Firms and a License Agreement with Merck Serono". Geneva. 2013-08-29
Bicoll GmbH. (8/29/13). "Press Release: Bicoll Announces a Fast Small Molecule Ligand Validation Method for Orphan Targets". 2013-08-29
Biognosys AG. (8/28/13). "Press Release: Biognosys’ Spectronaut Software Now Supports Thermo Scientific Q Exactive". Zürich-Schlieren. 2013-08-28
Merck KGaA. (8/28/13). "Press Release: James Stewart Appointed Chief Information Officer of Merck". Darmstadt. 2013-08-28
Actelion Ltd.. (8/27/13). "Press Release: Actelion Appoints André C. Muller as New Chief Financial Officer and Member of Actelion’s Executive Committee – Succeeding Andrew J. Oakley – Effective 01 September 2013". Allschwil. 2013-08-27
Merck KGaA. (8/27/13). "Press Release: Merck Praziquantel Donation Program to Treat Schistosomiasis Starts in Sudan. Donation of Six Million Tablets through the World Health Organization". Khartoum. 2013-08-27
PerkinElmer, Inc.. (8/27/13). "Press Release: PerkinElmer Opens Center for Innovation in Hamburg, Germany". 2013-08-27
Thermo Fisher Scientific Inc.. (8/27/13). "Press Release: Thermo Fisher Scientific Releases Next-generation Benchtop NMR Spectrometer". Madison, WI. 2013-08-27
Actelion Ltd.. (8/26/13). "Press Release: Ceptaris Receives US FDA Approval for Valchlor – a Significant Closing Condition of Actelion’s Acquisition of Privately-held Ceptaris". Allschwil. 2013-08-26
Ceptaris Therapeutics, Inc.. (8/26/13). "Press Release: Ceptaris Receives FDA Approval for Valchlor (mechlorethamine) Gel for the Treatment of State IA and IB Mycosys Fungoides-type Cutaneous T-Cell Lymphoma in Patients Who Have Received Prior Skin-direc 2013-08-26
Life Technologies Corporation. (8/26/13). "Press Release: Life Technologies Expands Food Testing Portfolio in Global Brewing and Beverage Industry. Partnership with PIKA Weihenstephan Will Ensure Consistency in Product Quality and Taste". Carlsbad, CA. 2013-08-26
MeVis Medical Solutions AG. (8/26/13). "Press Release: MeVis’ Profitability Remains High with Stable Revenues. Sales Increase of 9% in the Second Quarter Offsets Decline in Sales from Previous Quarter". Bremen. 2013-08-26
Roche. (8/26/13). "Press Release: Roche Introduces the First Globally-available HbA1c Test for Diagnosing Diabetes". Rotkreuz. 2013-08-26
Haplogen GmbH. (8/26/13). "Press Release: CeMM and Haplogen Make Available the World’s Largest Collection of Engineered Human Cell Lines for Biomedical Discovery". Vienna. 2013-08-26
Argos Therapeutics Inc.. (8/26/13). "Press Release: Argos Therapeutics Secues $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy". Durham, NC. 2013-08-26
Amgen Inc.. (8/25/13). "Press Release: Amgen to Acquire Onyx Pharmaceuticals for $125 per Share in Cash". Thousand Oaks, CA & South San Francisco, CA. 2013-08-25
Biofrontera AG. (8/23/13). "Press Release: Biofrontera AG Reports Half-year Financial Results for 2013". Leverkusen. 2013-08-23
Bavarian Nordic A/S. (8/22/13). "Press Release: Bavarian Nordic Reports Financial Results for the First Half of 2013". Kvistgaard. 2013-08-22
Evolva Holding S.A.. (8/22/13). "Press Release: Evolva Reports Interim Results for First Six Months of 2013". Reinach. 2013-08-22
Omnilab-Laborzentrum GmbH & Co. KG. (8/22/13). "Pressemitteilung: Omnilab-Laborzentrum GmbH & Co. KG und Serva Electrophoresis GmbH starten Vertriebskooperation". 2013-08-22
Basilea Pharmaceutica Ltd.. (8/21/13). "Press Release: Basilea Reports 2013 Half-year Financials with Improved Operating Results". Basel. 2013-08-21
Evonik Industries AG. (8/21/13). "Press Release: Evonik Opens Analytical Center for Animal Feed in Singapore". Hanau & Singapore. 2013-08-21
Evotec AG. (8/21/13). "Press Release: Evotec and the Jain Foundation Announce Extension of Research Collaboration in Skeletal Muscual Dystrophy Diseases". Hamburg. 2013-08-21
Medigene AG. (8/21/13). "Press Release: Medigene to Implement 4:1 Share Capital Reduction Effective 3 September 2013". Martinsried. 2013-08-21
University of Freiburg. (8/21/13). "Press Release: Research with the Moss Bioreactor. University of Freiburg and Greenovation Biotech to Cooperate on Improved Product Yields". Freiburg. 2013-08-21
Bayer AG. (8/20/13). "Press Release: Bayer’s Stivarga Approved for the Treatment of Patients with Gastrointestinal Stromal Tumors in Japan [No US and UK Media]". Berlin. 2013-08-20
Bremen, Senatskanzlei. (8/20/13). "Pressemitteilung: Gespräche zur Jacobs University erfolgreich abgeschlossen". 2013-08-20
Novartis AG. (8/20/13). "Press Release: Novartis Receives FDA Breakthrough Therapy Designation for BYM338 (bimagrumab) for Sporadic Inclusion Body Myositis (sIBM)". Basel. 2013-08-20
Bruker Corporation. (8/19/13). "Press Release: Bruker Announces the Appointment of Thomas Bachmann as President of the Bruker BioSpin Group". Billerica, MA. 2013-08-19
Universitätsklinikum Heidelberg. (8/19/13). "Pressemitteilung: Seltene Stoffwechselerkrankungen – 1,15 Millionen Euro for europaweites Forscher-Netzwerk". 2013-08-19
Fresenius SE & Co. KGaA. (8/19/13). "Press Release: Fresenius Kabi Enters Joint Venture on I. V. Generics". Bad Homburg v. d. H.. 2013-08-19
Manufactus GmbH. (8/16/13). "Pressemitteilung: Neues System zur Kanban-Verbesserung bei Eppendorf. Eppendorf ersetzt bestehendes Kanban-Tool durch das eKanban System IKS". 2013-08-16
Biognosys AG. (8/16/13). "Press Release: Spectral Library Generation". 2013-08-16
Boehringer Ingelheim. (8/16/13). "Press Release: Boehringer Ingelheim Takes a Further Step to Establish Animal Health Business in Asia. Ground-breaking Ceremony for Leading Veterinary Manufacturing Plant in Taizhou/China – Investment of 58 Million Euro". 2013-08-16
Lead Discovery Center GmbH. (8/16/13). "Press Release: LDC to Extend Its Successful Business Model by Launching Project Development Company Valeado. New Financing Vehicle Enables Investors to Participate in LDC’s Success". Dortmund. 2013-08-16
OpenChrom. (8/15/13). "Press Release: OpenChrom 0.8.0 »Dempster« with many New Features Now Available. Different Mass Spectrometers – One Software Solution". Hamburg. 2013-08-15
Thermo Fisher Scientific Inc.. (8/15/13). "Press Release: Thermo Fisher Scientific Establishes Pesticide Analysis Center of Excellence". San José, CA. 2013-08-15
Boehringer Ingelheim. (8/15/13). "Press Release: Boehringer Ingelheim Announces Full Patient Enrollment for Two of Its Pivotal Phase III Interferon-free Hepatitis C Clinical Trials [For media outside USA, UK and Canada only]". Ingelheim. 2013-08-15
Carl Zeiss AG. (8/14/13). "Press Release: Carl Zeiss Meditec AG Reaffirms Its Annual Target. Revenue Reached EUR 649 Million – EBIT Margin Inreased to 14.3 Percent – Forecast for Whole Year Confirmed". Jena. 2013-08-14
Sygnis Pharma AG. (8/14/13). "Press Release: Sygnis Reports Half-year Results for the Period Ended 30 June 2013". Madrid & Heidelberg. 2013-08-14
Tecan Group Ltd.. (8/14/13). "Press Release: Tecan Records Stable Sales and Increased Operating Profit in the First Half of 2013". Männedorf. 2013-08-14
Bayer AG. (8/14/13). "Press Release: Mobile Metering Units Made of High-tech Plastics from Bayer". Leverkusen. 2013-08-14
BioStorage Technologies, Inc.. (8/14/13). "Press Release: BioStorage Technologies Launches INTEGRITY Study to Measure Effect of Time, Temperature and Preparation Methods on DNA and RNA Samples". Indianapolis, IN. 2013-08-14
Universität zu Lübeck. (8/14/13). "Pressemitteilung: Neues EU-Projekt »nEUROinflammation«. Untersuchung von Entzündungsprozessen im Gehirm für bessere Therapien bei Schlaganfall und Multipler Sklerose". 2013-08-14
Mologen AG. (8/14/13). "Press Release: Mologen AG Further Advances Product Pipeline – Half-year Figures Presented. Final Evaluation of Colorectal Cancer Study with MGN1703 Confirms Positive Preliminary Results". 2013-08-14
Biotest AG. (8/13/13). "Press Release: Biotest Increases Earnings after Tax by 55%. New Sales Record in Second Quarter 2013". Dreieich. 2013-08-13
Galenica Holding AG. (8/13/13). "Press Release: Galenica Achieves Significant Milestones in the First Half of 2013 and Announces for 2013 Profit Growth for the 18th Consecutive Year". 2013-08-13
Actelion Ltd.. (8/12/13). "Press Release: Actelion Completes Share Repurchase Program of CHF 800 Million". Allschwil. 2013-08-12
next pagenext page 1 2 3 ... 55 56 57 ... 97 98 99  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [LSUS] – The Business Web Portal 600x60px

» top